SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
-8.84%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$391M
AUM Growth
+$391M
(-12%)
Cap. Flow
-$13.7M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
65.45%
Holding
31
New
2
Increased
13
Reduced
13
Closed
3
Top Buys
| 1 |
Globus Medical
GMED
|
$11M |
| 2 |
Bristol-Myers Squibb
BMY
|
$9.53M |
| 3 |
GE HealthCare
GEHC
|
$5.32M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$4.41M |
| 5 |
Elevance Health
ELV
|
$4.27M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$11.1M |
| 2 |
Baxter International
BAX
|
$10.6M |
| 3 |
Cardinal Health
CAH
|
$10.5M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$5.89M |
| 5 |
Becton Dickinson
BDX
|
$5.44M |
Sector Composition
| 1 | Healthcare | 99.26% |
| 2 | Consumer Staples | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kenvue
KVUE
$39.7B
| $2.89M | 0.74% |
+144,017
| New | +$2.89M |
|
|
AMED
27
DELISTED
Amedisys
AMED
| $2.3M | 0.59% |
24,585
-46,422
| -65% | -$4.34M |
|
28
Vir Biotechnology
VIR
$686M
| $1.39M | 0.36% |
148,538
-1,868
| -1% | -$17.5K |
|
29
Johnson & Johnson
JNJ
$427B
| – | – |
-26,471
| Closed | -$4.38M |
|
30
PTC Therapeutics
PTCT
$3.92B
| – | – |
-56,577
| Closed | -$2.3M |
|
|
NUVA
31
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-266,370
| Closed | -$11.1M |
|